Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 24.10.2024
Siltronic AG
Press release
Siltronic AG
Einsteinstrasse 172
81677 Munichwww.siltronic.com
Siltronic closes Q3 2024 in line with expectations
- Sales in the first nine months of 2024 declined 9.1 percent compared to the previous year; Q3 increased 1.7 percent q-o-q to EUR 357.3 million
- EBITDA margin remains solid at 25.7 percent after nine months (Q3 2 [ … ]
Thu, 24.10.2024
Siltronic AG
Press release
Siltronic AG
Einsteinstrasse 172
81677 Munichwww.siltronic.com
Siltronic closes Q3 2024 in line with expectations
- Sales in the first nine months of 2024 declined 9.1 percent compared to the previous year; Q3 increased 1.7 percent q-o-q to EUR 357.3 million
- EBITDA margin remains solid at 25.7 percent after nine months (Q3 2 [ … ]
Thu, 24.10.2024
Siltronic AG
Press release
Siltronic AG
Einsteinstrasse 172
81677 Munichwww.siltronic.com
Siltronic closes Q3 2024 in line with expectations
- Sales in the first nine months of 2024 declined 9.1 percent compared to the previous year; Q3 increased 1.7 percent q-o-q to EUR 357.3 million
- EBITDA margin remains solid at 25.7 percent after nine months (Q3 2 [ … ]
Thu, 24.10.2024
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Outlook 2024 confirmed: Flat year-on-year sales in CER and a CORE EBITDA margin of high 20s
Strong commercial and operational performance across the CDMO business in Q3; demand remains soft in Capsules & Health Ingredients and Bioscience businesses
Successful completion of the acquisition o [ … ]
Thu, 24.10.2024
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Outlook 2024 confirmed: Flat year-on-year sales in CER and a CORE EBITDA margin of high 20s
Strong commercial and operational performance across the CDMO business in Q3; demand remains soft in Capsules & Health Ingredients and Bioscience businesses
Successful completion of the acquisition o [ … ]
Thu, 24.10.2024
Lonza Group AG
Ad hoc announcement pursuant to Art. 53 LR
Outlook 2024 confirmed: Flat year-on-year sales in CER and a CORE EBITDA margin of high 20s
Strong commercial and operational performance across the CDMO business in Q3; demand remains soft in Capsules & Health Ingredients and Bioscience businesses
Successful completion of the acquisition o [ … ]
Thu, 24.10.2024
Temedica GmbH
PRESS RELEASE
Temedica and Roche extend successful partnership and celebrate milestones with digital patient companions
The successful collaboration between Temedica and Roche continues.
A five-figure number of patients have benefited from digital companion apps so far.
Innovative partnership as a key to improving patient care.
Muni [ … ]
Thu, 24.10.2024
Temedica GmbH
PRESS RELEASE
Temedica and Roche extend successful partnership and celebrate milestones with digital patient companions
The successful collaboration between Temedica and Roche continues.
A five-figure number of patients have benefited from digital companion apps so far.
Innovative partnership as a key to improving patient care.
Muni [ … ]
Thu, 24.10.2024
Temedica GmbH
PRESS RELEASE
Temedica and Roche extend successful partnership and celebrate milestones with digital patient companions
The successful collaboration between Temedica and Roche continues.
A five-figure number of patients have benefited from digital companion apps so far.
Innovative partnership as a key to improving patient care.
Muni [ … ]
Thu, 24.10.2024
Dynamics Group AG
Dynamics Group AG
/ Key word(s): Product Launch
Procivis One Is Now Open Source
24.10.2024 / 07:00 CET/CEST
Procivis One Is Now Open Source
Zurich, October 24, 2024 – Procivis, a leading pioneer in decentralized digital identity and verifiable credentials and a subsidiary of Orell Füssli, has announced the open source [ … ]